Хроматографический и масс-спектрометрический анализ модифицированных аналогов генно-инженерного инсулина человека
Диссертация
В настоящее время для терапии диабета 1-ого типа чаще всего используют генно-инженерный инсулин человека (ГИИЧ). Крупномасштабное производство и поставки этого препарата в нашу страну осуществляет ряд крупных иностранных фирм. В России его производство началось в Институте биоорганической химии им. академиков М. М. Шемякина и Ю. А. Овчинникова (ИБХ РАН). К сожалению, ГИИЧ не всегда идеально… Читать ещё >
Список литературы
- Barfoed Н.С. Insulin production technology. // Chem. Eng. Prog. -1987. -V.83.-P 49−54.
- Ladish M.R. Kohlmann K.L. Recombinant human insulin. // Biotechnol. Prog. -1992. -V. 461. -P. 469−478.
- Баирамошвили Д.И. Генно-инженерный инсулин человека: успехи и перспективы. // Рос. Хим. Ж. 2005. -Т. XLIX. -№ 1. -С. 34−45.
- Zimmet P., Alberti К. Shaw global and societal implication of the diabetes epidermic. // Nature. -2001. -V. 414. -P. 782−787.
- Watson J.D., Tooze J., Kurtz D.T. Recombinant DNA a short course scientific american books. N.Y.: W.H. Freeman Co. -1983. -P. 231−235.
- Brange J. Galenics of insulin. // Berlin: Springer-Verlag. -1987. -P.l-179.
- Owens D. R. New horizons-alternative routes for insulin therapy. // Nat. Rev. DrugDiscov. -2002. -V. 1. -P. 529−540.
- Brange J., VolundA. Insulin analogs with improved pharmacokinetic profiles.// Adv. DrugDeliv. Rev. -1999. -V. 35. -P. 307 335.
- Brange J. Protein delivery: Physical systems, NY: Plenum Press. -1997. -P. 343 -412.
- Старостина Е.Г. Инсулин и инсулинотерапия: «темный лес» или стройная система? // В мире лекарств. -1998. -№ 2.
- Morihara К., Ока Т., Tsuzuki Н. Semi-synthesis of human insulin. // United States Patent № 4.400.465, 1983.
- Obermeier R. Process for the manufacture of human insulin // United States Patent № 4.029.642, 1977.
- Van Dedem G.W.K., Van Houdenhofen F.E.A. Modified procine insulin and its use for preparing humani insulin. // United States Patent № 4.804.897, 1989.
- Баирамашвили Д.И., Гусаров Д. А., Давыдов В. И., Зинченко А. А., Косарев С. А., Ласман В. А., Мирошников А. И., Михалев А. В., Шибанова Е. Д. Способ получения генно-инженерного инсулина человека. // Патент
- Российской Федерации № 2 322 504 С1, заявка 26.06.2006, опубликован 20.04.2008 Бюл № 11.
- Гусарова В.Д., Гусаров Д. А., Миронов А. Ф., Баирамашвили Д. И., Мирошников А. И. Оптимизация промышленного получения рекомбинантного инсулина человека. // Биоорганическая химия. -2009. -Т. 35. -№ 4. -С. 510−518.
- Сергеев Н.В., Назимов И. В. Постадийный контроль производства рекомбинантного инсулина человека с помощью комплекса аналитических микрометодов. // Тезисы конференции Проблемы медицинской и экологической биотехнологии. Оболенск. 1999. С. 260.
- Kjeldsen T. Yeast Secretory Expression of Insulin Precursors. // Application of Microbiological Technology. 2000. -V. 54. -P. 277−286Г68.
- Nadler J.L., Balon T.W., Yamaguchi Y. Method of enhancing insulin action // United States Patent № 6 316 458, 2001.
- Tchelingerian J.-L. Insulin conjugates and methods of use thereof // United States Patent Application № 20 030 153 490, 2003.
- Huus К, Havelund S., Olsen H. В., Weet M. van de, Frokjaer S. Thermal dissociation and unfolding of insulin // Biochemistry. -2006. -V. 45. -P. 4014 -4024.
- Bhatnagar S., Srivastava D., Jayadev M. S. K., Dubey A. K. Molecular variants and derivatives of insulin for improved glycemic control in diabetes // Progr. in Biophysics and Molecular Biology. -2006. -V. 91. -P. 199 228.
- Brange J. Studies of insulin stability // Netherlands, Academic Publishers. -1994. -P. 17−37.
- Dodson G. G., Steiner D. The role of assembly in insulin’s biosynthesis. // Curr. Opin. Struct. Biol. -1998. -V. 8. -P. 189 194.
- Brange J., Langkjaer L. Chemical stability of insulin. 3. Influense of excipients, formulation and pH. // Acta Pharm. Nord. -1992. -P. 149 158.
- Blundell T. L. Three-dimensional atomic structure of insulin and its relation to activity. //Diabetes. -1972. -V. 21. -P. 492 505.
- Heinemann L., Starke AA.R., Hohmann A, Berger M. Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. // Horm. Metab. Res. -1992. -V. 26(S). -P. 137 139.
- Hvaas A., Skelbaek-Pedersen B. Determination of protamine peptides in insulin drug products using reversed phase high performance liquid chromatography // J. Pharm. and Biomed. Analysis. -2005. -V. 37. -P. 551 557.
- Hallas-Moller K., Petersen K., Schlichtkrull J. Crystalline and Amorphous Insulin-Zinc Compounds with Prolonged Action // Science. -1952. -V. 116 (3015). -P.394 398.
- Hoffman J. A, Chance R. E., Johnson M. G. Purification and analysis of the major components of chum salmon protamine contained in insulin formulations using high performance liquid chromatography. // Prot. Exp. Purif. -1990. -V. 1. -P. 127- 133.
- Samuel S.E., Kolk AH, Rumke P. Studies on the immunogenicity of protamines in humans and experimental animals by means of a micro complement fixation test. //Clin. Exp. Immunol. -1978. -V. 33. -P. 252−260.
- Ando Т., Yamasaki M., Suzuki К. Protamines, isolation, characterization structure and function//Berlin: Springer-Verlag, -1973. -P. 1 117.
- Markussen J., Jonassen lb., Havelund S., Brandt J., Kurtzhals P., Hansen P.-H., Kaarsholm N. Ch. Insulin derivatives //United States Patent № 6 620 780, 2003.
- Derewenda U., Derewenda Z., Dodson E. J., Dodson G. G., Reynolds C. D., Smith G. D., Sparks C., Swenson D. Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer// Nature. -1989. -V. 338. -P. 594 596.
- Yomota C, Yoshii Y, Takahata Т., Okada S. Separation of B-3 monodesamidoinsulin from human insulin by high-performance liquid chromatographi under alkaline conditions // J. Chromatogr. A. -1996. -V. 721. -P. 89 96.
- Reichard O., Nilsson B.-Y., Rosenquist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. //N. Engl. J. Med. -1993. -V. 329. -P. 304 309.
- Wong P.H., Lau J., Chalmers T.S. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. // Lancet. -1993. -V. 341. -P. 1306−1309.
- Starke A.A., Heinemann L., Hohmann A., Berger M. The action profiles of human NPH insulin preparations. //Diabet. Med. -1989. -V. 15. -P. 239−244.
- Jehle P.M., Micheler C., Jehle D.R., Breitig D., Boehm B.O. Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens. // Lancet. -1999. -V. 354. -P. 1057- 1065.
- Homko C., Deluzio A., Jimenez C., Kolaczynski J.W., Boden G. Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects // Diabetes Care. -2003. -V. 26. -P. 2027 2031.
- Osterberger O., Erichsen L., Ingwersen S.H., Plum A., Poulsen H.E., Vicini P. Pharmacodynamics and pharmacokinetics of insulin and insulin analogs // J. Pharmacokinetics and Pharmacodynamics. -2003. -V. 30. -№ 3. -P 221−235(15).
- Owens D. R., Zinman В., Bolli G. B. Insulins today and beyond. // Lancet. -2001.-V. 358.-P. 739−746.
- Brange J. The new era of biotech insulin analogues. // Diabetologia. -1977. -V. 40. -P. S48 S55.
- Balschmidt P., Brange J.J.V. Human insulin analogs. // United States Patent Application № 20 013 269, 2002.
- Plank J., Wutte A., Brunner G., Siebenhofer A., Semlitsch В., Sommer R., Hirschberger S., Pieber T.R. A direct comparison of insulin aspart and insulin lispro in patiets with type 1 diabetes. // Diabetes Care. 2002 V. 25. -№ 11. -P. 2053−2057
- Becker R., Frick A., Wessels D., Scholtz H. Pharmacodynamic and pharmacokinetics of a new, rapidly acting insulin analog, insulin glulisin. // Diabetes. -2003. -V. 52. -P. A110.
- Dailey G., Rosenstock J., Moses R.G., Ways K. Insulin glulisine provides improved glycemic control in patients with type 2 diabetes. // Diabetes Care. -2004. -V. 27. -P. 2363 2368.
- Plakogiannis R., Nathan J. P., Rosenberg J. M. How are insulin glargine and insulin aspart different from the older insulins? // Drug Topics. -2000. -V. -144. -№ 22.-P. 41.-47.
- Bolli G. В., Owens D. R. Insulin glargine. // Lancet. 2000. -V. 356. -P. 443 -445.
- Bolli G. В., Di Marchi R. D., Park G. D., Pramming S., Koivisto V. A. Insulin analogues and their potential in the management of diabetes mellitus. // Diabetologia. -1999. -V. 42. -P. 1151 1167.
- Tan С Y., Wilson D. M., Buckingham B. Initiation of insulin glargine in children and adolescents with type 1 diabetes. // Pediatric Diabetes. -2004. -V. 5. -P. 80 86.
- Home P. Insulin glargine: the first clinically useful extended-acting insulin in half a century. //Expert Opin. Invest. Drugs. -1999. -V. 8 (3). -P. 307 314.
- Berger M. Safety of insulin glargine. // Lancet. -2000. -V. 356. -P. 2013 -2014.
- Calceti P., Salmaso S., Walker G., Bernkop-Schnurch A. A development and in vivo evaluation of an oral insulin-PEG delivery system. // Eur. J. Pharm. Sci. -2004. -V. 22(4). -P. 315−323.
- Molineux G. Pegylation: engineering improved pharmaceuticals for enhanced therapy. // Cancer Treat. Rev. -2002. -V. 28 (A). -P. 13 16.
- Pasut G., Veronese M. PEGylation of proteins as tailored chemistry for optimized bioconjugates //Adv. in Polymer Science. -2006. V. 192. -P. 95−134.
- Gregoriadis G., Jain S., Papaioannou I., Laing P. Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids. // Int. J. of Pharmaceutics. -2005. -V. 300. -P. 125 130.
- Caliceti P., Veronese F.M. Pharmacokinetic and biodistribution properties of poly (ethylene glycol)-protein conjugates. // Adv. Drug Delivery Rev. -2003. -V. 55. -P. 1261−1277.
- Gregoriadis G., McCormack В., Wang Z., Lifely R. Polysialic acids: potential in drug delivery. // FEBS Lett. -1993. -V. 315. -P. 271−276.
- Gregoriadis G., Fernandes A., McCormack B. Polysialylated proteins. An approach to improving enzyme stability and half-life in the blood circulation. // S.T.P. PHARMA SCIENCES. -1995. -V. 9 (1). -P. 61−66.
- Valuev L., Valuev L.I., Plate N.A. New possibilities for biospecific chromatography. // Appl. Biochem. and Microbiol. -2003 -V. 39. №. 4. -P. 422 -442.
- Корчажникова M.H., Назимов И. В., Глубоков Ю. М., Безуглов В. В. Исследование полисиалированного генно-инженерного инсулина человека. / Вестник МИТХТ. -2009. -Т. 4. -№ 2. -С. 77−79.
- Корчажникова М.Н., Назимов И. В., Глубоков Ю. М., Безуглов В. В. Хроматографический и масс-спектрометрический анализ анализ гликозилированного генно-инженерного инсулина человека. / Вестник МИТХТ. -2009. -Т. 4. -№ 5. -С. 37 39.
- DennisM. S., ZhangM., Meng Y. G., KadhodayanM., Kirchhofer D., Combs D., Damico L. A. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. // J. Biol. Chem. -2002. -V. -277. -P. 35 035 35 043.
- Kurtzhals P., Havelund S., Jonassen I., Kiehr В., Larsen U. D., Ribel U., Markussen J. Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue. //Biochem. J. -1995. -V. 312. -P. 725 731.
- KjeldsenT.B., Ludvigsen S., Kaarsholm R.C. Method for making insulin precursors and insulin precursor analogs // United States Patent Application № 20 010 023 069, 2001.
- Balschmidt P., Brange J.J.V. Human insulin analogs. // United States Patent Application № 20 020 013 269. 2002.
- Gomez-Perez F. J., Rull J. A. Insulin therapy: current alternatives. // Arch, of Med. Res. -2005. -V. 36. -P. 258 272
- Whittingham J. L., Havelund S., Jonassen I. Crystal structure of a prolonged-acting insulin with albumin-binding properties. // Biochemistry. -1997. -V.36. -№ 10. -P. 2826−2831.
- Huus K., Havelund S, Olsen H.B., Marco van de Weert, Frokjaer S. Thermal Stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer. // Pharm. Research. -2006 V. 23. -№ 11. -P. 2611 2611.
- Сочилина К.О., Некипелова В. О., Гусаров Д. А. Гидрофобные полимерные гели российского производства для обессоливания и очистки белков. // Биофарм. Ж. -2009. -Т. 1. -№ 1. -С. 23 26.
- Manzi Е., Higa Н., Diaz S., Varki A. Intramolecular self-cleavage of polysialic acid. //J. of Biological Chem. -1994. -V. 269. -№ 38. -P. 23 617 23 624.
- Sadako Inoue, Shu-Ling Lin, Yuan Chuan Lee, Yasuo Inoue / An ultrasensitive chemical method for polysialic acid analysis.// J. of Biological Chem. -2005. -V. 280. -No. 46. -P. 38 305−38 316.
- Sadako Inoue, Shu-Ling Lin, and Yasuo Inoue Chemical analysis of the developmental pattern of polysialylation in chicken brain. // J. of Biological Chem. -2000. -Y. 275. -№. 39. -P. 29 968 29 979.
- Lloyd L. F,.Corran P. Н. Analysis of insulin preparations by reversed-phase high-performance liquid chromatography. // J. Chtomatogr. -1982. -V. 240. -P. 445 -454.
- Rivier J., McClintock R. Reversed-phase high-performance liquid chromatography of insulin from different species. // J. Chromatogr. 1983. V. 268. P. 112−119
- Yomota С., Yoshii Y, Takahata N., Okada S. Separation of B-3 desamidoinsulin from human insulin by high-performance liquid chromatography under alkaline conditions. // J.Chromatogr. A. -1996. -V. 721. -P. 89 96.
- Damgaard U, Markuseen T.J. Analysis of insulins and related compounds by HPLC. // Horm. Metab. Res. -1979.-V. II. -P. 580 581.
- Parman, A. U. Rideout, J. M. Purification of porcine insulin by high-performance liquid chromatography. // J. Chromatogr. -1983. -V. 256. -P. 283 -291.
- McLeod A.N., Mauer.A., Wood.S.P. / High-performance liquid chromatography of insulin. //J.Chromatogr. -1990. -V. 502. -P. 325 336.
- Guevara O.L., Estrada G., Antonio S., Alvarado X., Guereca L., Zamudio F., Bolivar F. Identification and isolation of human insulin A and В chains by high-performance liquid chromatography. // J.Chromatogr. -1985. -V. 349. -P.91 -98.
- Seino S., Funakoshi A., Fu ZZ., Vinik A. Identification of insulin variants in patients with hyperinsulinemia by reversed-phase high-performance liquid chromatography. // Diabetes. -1985. -V. 34. -P. 1 7.
- Peter A., Szepesi G., Balaspiri L., Burger K. Coordinative interactions in the separation of insulin and its derivatives by high-performance liquid chromatography. // J. Chromatogr. -1987. V. 408. -P. 43 52.
- Szepesi G, Gazgad M. Imroved high-performance liquid chromatographic method for the analysis of insulins and related compounds. // J. Chromatogr. -1981.-V. 218.-P. 597−602.
- Szepesi G, Gazgad M. Separation of large polypeptides by high-performance liquid chromatography. // J. Chromatogr. -1981. -V. 218. -P. 603 -612.
- Pikal M.J., Rigsbee D.R. The Stability of insulin in cristalline and amorphous solids: observation of greater stability for the amorphous form. // Pharm.Res. -1997. -V. 14. -P. 1379 1387.
- Rubinstein M Chen-Kiang S., Stein S., Udenfriend S. Characterization of proteins and peptides by high-performance liquid chromatography and fluorescence monitoring of their tryptic digests. // Anal.Biochem. -1979. -V. 95. -P. 117- 121.
- Rivier J., McClintock. Reversed-phase high-performance liquid chromatography of insulins from different species. // J. Chromatogr. -1983. -V. 268.-P. 112- 119.
- Kroeff E.P., Owens.R.A., Campbell E.L., Johnson R.D., Marks H.I. Production scale purification of biosynthetic human insulin by reversed-phase high-performancel liquid chromatography. //J. Chromatogr. -1989. -V. 461. -P. 45 -61.
- Rubinstein M. Preparative high-performance liquid partition chromatography of proteins. // Anal. Biochem. -1979. -V. 98. -P. 1−7.
- Welinder B.S., Sorensen H.H., Hansen B. Reversed-phase high-performance liquid chromatography of insulin. Resolution and recoveiy in relation to column geometry and buffer components. // J. Chromatogr. -1986. -V. 361. -P. 357 367.
- Tuesca D., Reiff C., Joseph I., Lowman M. Synthesis, characterization and in Vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels. // Pharm. Res. -2009. -Vol. 26. -№ 3. -P. 727 739.
- Nielsen, R.G., Sittampalam G.S., Rickard, E.C. Capillary zone electrophoresis of insulin and growth hormone // Anal. Biochem. -1989. -V. 177. -P. 20 26.
- Yomota С., Matsumoto Y., Okada S., Hayashi Y., Matsuda R. Discrimination limit for purity test of human insulin by capillary electrophoresis. // J. Chromatogr. B. -1997. -V. 703. -P. 139 145.
- Arcelloni C., Fermo I., Banfi G., Pontiroli A.E., Paroni R. Capillary electrophoresis for protein analysis: separation of human growth gormone and human insulin molecular forms //Anal. Biochem. -1993. -V. 212. -P. 160 167.
- Степанов B.M. Молекулярная биология. Структура и функции белков. -М.: Наука, 2005,-336 с.
- Практическая химия белка / Под ред. А. Дарбре, пер. с англ. Н. А. Алданова, И. В. Назимов, П. Д. Решетова, М.: Мир, 1989, 611 с.
- Овчинников Ю.А. Биоорганическая химия. М: Просвещение, 1987, -815 с.
- Лебедев А.Т. Масс-спектрометрия в органической химии. М.: Бином, 2003, — 493 с.
- Артеменко К.А., Самгин Т. Ю., Лебедев А. Т. Масс-спектрометрическое de novo секвенирование пептидов // Масс-спектрометрия. -2006 -Т. -3. -№ 4. -С. 225−253.